INDUCTION OF EPITHELIAL ABNORMALITIES THAT RESEMBLE HUMAN BREAST-LESIONS BY THE EXPRESSION OF THE NEU ERBB-2 ONCOGENE IN RECONSTITUTED MOUSE MAMMARY-GLAND/
Jm. Bradbury et al., INDUCTION OF EPITHELIAL ABNORMALITIES THAT RESEMBLE HUMAN BREAST-LESIONS BY THE EXPRESSION OF THE NEU ERBB-2 ONCOGENE IN RECONSTITUTED MOUSE MAMMARY-GLAND/, Oncogene, 8(6), 1993, pp. 1551-1558
We have developed a transplantation system that allows us to introduce
oncogenes into mouse mammary epithelial cells in culture and then to
reconstitute an epithelial tree in vivo from the genetically altered c
ells. Introduction of the neu oncogene, a transforming homologue of th
e human proto-oncogene c-erbB-2, produced a variety of abnormal patter
ns of epithelial growth, many of which resembled lesions found in huma
n breasts. In four of 43 oncogene-bearing glands, areas of ductal carc
inoma in situ were found, an abnormality previously observed in transg
enic neu-bearing mice. Six glands developed localized areas of dense s
troma containing excess ductal structures comprised of mildly hyperpla
stic epithelium. These areas resembled the human breast lesion termed
sclerosing adenosis. Other glands developed hyperplastic epithelium, s
ometimes with multilayering of the cells and/or atypical changes such
as abnormally large nuclei. In human breasts such lesions would be ter
med mild or atypical hyperplasia. In all the abnormal areas examined,
levels of neu protein above background level were detected by immunohi
stochemistry. Some staining was localized to membranes (as observed in
ductal carcinoma in situ in humans) but cytoplasmic staining was also
common in the lesions induced in mice by the neu oncogene. The range
of abnormalities seen in the reconstituted glands carrying the neu onc
ogene suggests that the matching lesions in the human breast may be st
ages on one pathway to tumour development.